BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 374200)

  • 1. [Preliminary results of a continuous study protocol with adjuvant chemotherapy in primary operable breast carcinoma].
    Cavalli F; Jungi F; Alberto P; Martz G; Brunner KW
    Haematol Blood Transfus; 1978; 22():61-6. PubMed ID: 374200
    [No Abstract]   [Full Text] [Related]  

  • 2. Surgery and adjuvant chemotherapy in the treatment of operable breast cancer.
    Rossi A; Valagussa P; Bonadonna G
    Prog Clin Biol Res; 1977; 12():391-404. PubMed ID: 335401
    [No Abstract]   [Full Text] [Related]  

  • 3. Adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil, vincristine, and prednisone compared with single-agent L-phenylalanine mustard for patients with operable breast carcinoma and positive axillary lymph nodes: 20-year results of a Southwest Oncology Group study.
    Rivkin SE; Green SJ; Lew D; Costanzi JJ; Athens JW; Osborne CK; Vaughn CB; Martino S
    Cancer; 2003 Jan; 97(1):21-9. PubMed ID: 12491501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant chemotherapy with four drugs for stage 2 breast cancer.
    Wheeler TK; Edelstyn GA; Bates TS; Brinkley D; Evans RG; Kitchen G; MacRae KD; Nicol NT; Spittle M; Wheeler TK
    Eur J Cancer (1965); 1980; Suppl 1():161-3. PubMed ID: 7032926
    [No Abstract]   [Full Text] [Related]  

  • 5. The case for adjuvant CMF chemotherapy in breast cancer. Has it been made?
    Levitt SH; Potish RA
    Cancer Clin Trials; 1981; 4(4):363-9. PubMed ID: 7032731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant chemotherapy, anti-estrogen therapy and immunotherapy for stage II breast cancer.
    Hubay CA; Pearson OH; Marshall JS; Rhodes RS; Debanne SM; Mansour EG; Hermann RE; Jones JC; Flynn WJ; Eckert C; McGuire WL
    Eur J Cancer (1965); 1980; Suppl 1():189-95. PubMed ID: 7032932
    [No Abstract]   [Full Text] [Related]  

  • 7. [Evaluation of the toxicity of precautional chemotherapy with cyclophosphamide, methotrexate and 5-fluorouracil (CMF) in carcinoma of the breast in the first 700 treatment cycles].
    Sismondi P; Zola P; Galletto L; De Giovanni D; Giardina G
    Minerva Ginecol; 1979; 31(7-8):563-8. PubMed ID: 481814
    [No Abstract]   [Full Text] [Related]  

  • 8. Surgical adjuvant trials in the United States.
    Rozencweig M; Von Hoff DD; Allegra JC; Muggia FM
    Eur J Cancer (1965); 1980; Suppl 1():173-7. PubMed ID: 7032929
    [No Abstract]   [Full Text] [Related]  

  • 9. A pilot study of sequential combination chemotherapy with adriamycin and cyclophosphamide, and methotrexate, 5-fluorouracil and prednisolone in advanced breast cancer.
    Collis CH
    Br J Clin Pract; 1978 May; 32(5):139-44. PubMed ID: 666968
    [No Abstract]   [Full Text] [Related]  

  • 10. Trials of adjuvant chemotherapy in breast cancer. The experience of the Istituto Nazionale Tumori of Milan.
    Rossi A; Bonadonna G; Tancini G; Bajetta E; Marchini S; Valagussa P; Veronesi U
    Eur J Cancer (1965); 1980; Suppl 1():149-56. PubMed ID: 7032924
    [No Abstract]   [Full Text] [Related]  

  • 11. [CMF (cyclophosphamide, methotrexate, ftorafur) chemotherapy in advanced breast cancer].
    Gottwald G; Szakolczai I
    Orv Hetil; 1983 Jan; 124(2):79-84. PubMed ID: 6687491
    [No Abstract]   [Full Text] [Related]  

  • 12. Neoadjuvant-preoperative-chemotherapy for breast cancer--preliminary report of the Vancouver trial.
    Ragaz J; Baird R; Rebbeck P; Coldman A; Goldie J
    Prog Clin Biol Res; 1985; 201():77-87. PubMed ID: 3912768
    [No Abstract]   [Full Text] [Related]  

  • 13. [Adjuvant chemotherapy of primary breast cancer].
    Heuson JC; Mattheiem WH
    Acta Chir Belg; 1977; 76(4):437-43. PubMed ID: 919991
    [No Abstract]   [Full Text] [Related]  

  • 14. [Combination chemotherapy in advanced carcinoma of the breast].
    Carmo-Pereira J; Galvão-Teles A; Oliveira Costa F; Bak Gordon R; Henriques E; Dória JM; Freire Cruz M; Silveira Botelho L
    Arq Patol; 1974; 46(2-3):309-23. PubMed ID: 4458643
    [No Abstract]   [Full Text] [Related]  

  • 15. A randomized trial of adjuvant combination chemotherapy with or without prednisone in premenopausal breast cancer patients with metastases in one to three axillary lymph nodes.
    Ludwig Breast Cancer Study Group
    Cancer Res; 1985 Sep; 45(9):4454-9. PubMed ID: 2862995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Management of advanced breast cancer in post-menopausal women. A comparative trial of hormonal therapy, chemotherapy, and a combination of both].
    Clavel B; Cappelaere JP; Guerin J; Klein T; Pommatau E; Berlie J
    Sem Hop; 1982 Sep; 58(34):1919-23. PubMed ID: 6293073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Results of, and indications for adjuvant chemotherapy in breast cancer].
    Brunner KW; Goldhirsch A; Joss R; Sonntag RW; Tschopp L
    Schweiz Med Wochenschr; 1981 Jun; 111(23):838-45. PubMed ID: 7268339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Grand Rounds: Adjuvant therapy of breast cancer.
    Va Med; 1977 Oct; 104(10):709-15. PubMed ID: 919723
    [No Abstract]   [Full Text] [Related]  

  • 19. CMF versus CMF plus tamoxifen in advanced breast cancer in postmenopausal women. An EORTC trial.
    Mouridsen HT; Palshof T; Engelsman E; Sylvester R
    Eur J Cancer (1965); 1980; Suppl 1():119-23. PubMed ID: 7032921
    [No Abstract]   [Full Text] [Related]  

  • 20. Adjuvant combination chemotherapy for operable breast cancer. Trials in progress at the Istituto Nazionale Tumori of Milan.
    Bonadonna G; Rossi A; Tancini G; Bajetta E; Marchini S; Brambilla C; Tesoro Tess JD; Valagussa P; Banfi A; Veronesi U
    Cancer Treat Rep; 1981; 65 Suppl 1():61-5. PubMed ID: 7034930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.